AI-Enhanced PROMs and Drug-Drug Interaction Screening in Advanced Breast Cancer: Protocol of a Prospective Observational Pilot Study
BackgroundIn advanced breast cancer, treatment pathways are becoming increasingly prolonged and complex across different biological subtypes. New systemic and targeted therapies require long-term monitoring and careful personalization according to patient-specific factors that demand increasingly individualized therape...